XXS-13225-06339
3 vaccinations
5 coded responses
38 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 283 / NC
- Registered
- 2022-01-10
- Relationship
- Child or adolescent in my care
- Guardian
- 2XS-27094-03343
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-10
Registered in v-safe
-
2022-01-10
Dose 1 — Pfizer-BioNTech
- 2022-01-10
-
2022-01-11
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Abdominal painAdult check-in
-
2022-01-12
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Dizziness — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend schoolFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-01-14
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Poor · Fatigue or tiredness, Abdominal painAdult check-in
- 2022-01-15
- 2022-01-16
- 2022-01-17
- 2022-01-24
-
2022-01-31
Dose 2 — Pfizer-BioNTech
- 2022-01-31
-
2022-02-01
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-02-02
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2022-02-03
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Headache, Joint pains, Abdominal painAdult check-in
- 2022-02-04
-
2022-02-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Fever · Headache, Abdominal painAdult check-in
-
2022-02-06
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Headache, Abdominal painAdult check-in
-
2022-02-07
Health check-in — day 7, dose 2, dependentFeeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-02-14
-
2022-02-21
Survey response — day 21, dose 2, dependentMedDRA: Headache — Feeling: Fair · Be unable to work or attend schoolFree text: Headache (moderate)MedDRA releases: 2024-11 · check-in free text available
- 2022-02-28
- 2022-03-07
-
2022-03-16
Survey response — day 42, dose 2, dependentMedDRA: Headache — Feeling: Good · Be unable to work or attend schoolFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-05-02
- 2022-08-01
-
2022-08-10
Dose 3 — Pfizer-BioNTech
-
2022-08-11
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Poor · Site: Pain · Fever · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-08-12
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-08-13
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · HeadacheAdult check-in
-
2022-08-14
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Headache, Muscle or body achesAdult check-in
- 2022-08-15
- 2022-08-16
- 2022-08-17
- 2022-08-24
- 2022-08-31
-
2022-09-07
Survey response — day 28, dose 3, dependentMedDRA: Headache, Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: Recurring sore throat and headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-09-16
- 2022-09-21
- 2022-11-09
-
2023-02-08
Survey response — 6 months, dose 3, dependentMedDRA: Pre-existing disease — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-10 | Pfizer-BioNTech | No |
| 2 | 2022-01-31 | Pfizer-BioNTech | No |
| 3 | 2022-08-10 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Dizziness
Release 11 — day 21, dose 2, dependent
Symptoms: Headache (moderate)
Release 11 — day 42, dose 2, dependent
Symptoms: Headache
Release 12 — day 28, dose 3, dependent
Symptoms: Recurring sore throat and headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release